Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Profit After Tax (2016 - 2025)

CorMedix has reported Profit After Tax over the past 16 years, most recently at $108.6 million for Q3 2025.

  • Quarterly results put Profit After Tax at $108.6 million for Q3 2025, up 4009.63% from a year ago — trailing twelve months through Dec 2025 was $131.2 million (up 831.93% YoY), and the annual figure for FY2025 was $1.7 million, up 109.48%.
  • Profit After Tax reached $108.6 million in Q3 2025 per CRMD's latest filing, up from $2.0 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $108.6 million in Q3 2025 and bottomed at -$14.8 million in Q4 2023.
  • Median Profit After Tax over the past 5 years was -$7.6 million (2022), compared with a mean of $476653.9.
  • The largest annual shift saw Profit After Tax plummeted 79.77% in 2023 before it skyrocketed 4009.63% in 2025.
  • Over 5 years, Profit After Tax stood at -$7.8 million in 2021, then dropped by 5.34% to -$8.2 million in 2022, then tumbled by 79.77% to -$14.8 million in 2023, then surged by 191.26% to $13.5 million in 2024, then skyrocketed by 706.3% to $108.6 million in 2025.
  • Business Quant data shows Profit After Tax for CRMD at $108.6 million in Q3 2025, $2.0 million in Q2 2025, and $20.6 million in Q1 2025.